ReviewPharmaceutics2026
Cold Plasma-Enabled Interface Engineering and In-Situ Functionalization of Printable Feedstocks in Additive Manufacturing: Mechanisms, Materials, and Applications.
Review in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cold plasma (CP) has emerged as a multifunctional surface engineering technology capable of enabling precise, non-thermal modification of material interfaces, while additive manufacturing (AM) has transformed modern fabrication through a layer-by-layer model of personalized therapies. This review discusses potential interactions between cold plasma technologies and additive manufacturing processes for pharmaceutical and biomedical applications. CP has been investigated for surface modifications before and after manufacturing processes in several material science applications. Through controlled surface activation and plasma-induced chemistry, CP-assisted processes can enhance interlayer adhesion, surface wettability, antimicrobial activity, and bioactivity of AM-fabricated models, by generating reactive species and introducing functional groups into the surfaces of materials. The review also discusses engineering and regulatory challenges associated with plasma technologies in AM. Overall, CP represents a versatile surface modification technology whose interaction with materials used in AM deserves further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.